114 related articles for article (PubMed ID: 7585572)
1. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer.
Kaklamanis L; Leek R; Koukourakis M; Gatter KC; Harris AL
Cancer Res; 1995 Nov; 55(22):5191-4. PubMed ID: 7585572
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
3. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
4. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
5. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
[TBL] [Abstract][Full Text] [Related]
7. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
[TBL] [Abstract][Full Text] [Related]
9. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
10. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
11. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA class I antigen and proteasome subunits LMP-2 and LMP-10 in primary vs. metastatic breast carcinoma lesions.
Gobbi G; Mirandola P; Micheloni C; Solenghi E; Sponzilli I; Artico M; Soda G; Zanelli G; Pelusi G; Fiorini T; Cocco L; Vitale M
Int J Oncol; 2004 Dec; 25(6):1625-9. PubMed ID: 15547699
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S
Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358
[TBL] [Abstract][Full Text] [Related]
14. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
15. MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding.
Ortmann B; Androlewicz MJ; Cresswell P
Nature; 1994 Apr; 368(6474):864-7. PubMed ID: 8159247
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
[TBL] [Abstract][Full Text] [Related]
17. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
[TBL] [Abstract][Full Text] [Related]
18. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
[TBL] [Abstract][Full Text] [Related]
19. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
20. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.
Liu Y; Komohara Y; Domenick N; Ohno M; Ikeura M; Hamilton RL; Horbinski C; Wang X; Ferrone S; Okada H
Cancer Immunol Immunother; 2012 Jun; 61(6):789-801. PubMed ID: 22065046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
